Switch Mobility to roll out ultra low-floor e-buses to STCs soon
The Hindu
Switch Mobility to deliver 1,200+ ultra low-floor buses and 100 inter-city buses, CEO Mahesh Babu announces upcoming launches.
Switch Mobility, the EV arm of Ashok Leyland, will start delivering more than 1,200 ultra low-floor buses and 100 inter-city buses in the coming months, said CEO Mahesh Babu.
“We are gearing up to launch EiV12 m ultra floor buses and EiV inter-city buses in the next one month for couple of state transport corporations,” Mr. Babu said during an interaction.
According to him, the company has orders for 2,000 e-buses that would be delivered over a period of 12-18 months.
“Next month, Switch will deliver 950 e-buses for Delhi STC and 320 for the Bengaluru Metropolitan Transport Corporation. These buses will deliver a range of 300 km on a single charge and can accommodate 34-38 passengers,” the CEO said.
About 100 mofussil inter-city e-buses would be delivered to UPSRTC. These buses, manufactured at the Ennore plant, would also deliver a 300-km range and could seat 40 passengers, he added.
Welcoming the PM E-Drive scheme, Mr. Babu said the scheme would benefit 24 lakh vehicles, including 28,000 electric buses.
Under the scheme, subsidies/demand incentives worth ₹3,679 crore have been provided for e-2Ws, e-3Ws, e-ambulances and e-trucks. The scheme will support 24.79 lakh e-2Ws, 3.16 lakh e-3Ws, and 14,028 e-buses.
Stock markets decline after two days of gains, with subdued trading expected amid a holiday-shortened week.
Rupee dips to 89.73 against the dollar as Sensex and Nifty also decline amid FII outflows and weak market conditions.
Mercedes-Benz settles multistate emissions allegations for $149.6 million, addressing illegal devices in over 211,000 vehicles.
U.S. approves Wegovy pill for weight loss, expanding access to obesity treatment with a convenient daily oral option.
RBI Bulletin highlights resilient economic activity in India, driven by robust demand, despite challenges in external trade and inflation.
Biofabri and Bharat Biotech partner to advance MTBVAC, a tuberculosis vaccine, ensuring equitable access and manufacturing readiness in India.
India anticipates doubling trade with New Zealand to $5 billion in five years following a historic women-led free trade agreement.
Rupee dips 3 paise to 89.70 against the dollar amid trade deal concerns and rising crude oil prices.
Government to release new series of retail inflation, GDP data from February, IIP from May next year
The Indian government will release new macroeconomic data series, including GDP and inflation, starting February 2026.
Granules India secures U.S. FDA tentative approval for its ADHD generic, enhancing access to critical therapy and expanding its generics portfolio.
Italy’s competition authority (AGCM) said on Monday it had fined U.S technology giant Apple and two of its divisions 98.6 million euros ($115.53 million) over alleged abuse of their dominant position in the mobile app market.
India denies duty concessions on dairy imports from New Zealand in recent trade pact negotiations, prioritizing local farmers' protection.
India-New Zealand free trade agreement offers zero-duty access, $20 billion investment pledge, and enhanced trade in multiple sectors.